From Molecule To Market. Every Assay Validated, Tracked, And Compliant.
Pharmaceutical laboratories operate under the most demanding regulatory scrutiny in any industry. LIMSera provides the data integrity, study management, and compliance infrastructure that biopharma labs need to move from bench to regulatory submission — with every data point defended.
When Data Integrity Fails, Drug Development Stops.
Pharmaceutical and bioanalytical laboratories face regulatory pressure that intensifies with every FDA warning letter and EMA non-compliance finding. Data integrity is no longer a quality aspiration — it is an existential requirement. A single unattributed data entry, an unexplained modification, or a missing audit trail entry can trigger a regulatory action that delays a drug programme by months or years.
Yet many pharma labs still rely on paper logbooks for observations, spreadsheets for stability trending, and manual document assembly for regulatory submissions. Method validation records are scattered across instruments and file servers. OOS investigations follow informal processes that lack the documentation rigour that inspectors expect. Electronic signatures exist in name but lack the meaning declarations and audit trail depth that 21 CFR Part 11 demands.
LIMSera embeds data integrity, regulatory compliance, and study traceability into the laboratory's daily workflow — so compliance is structural, not aspirational, and inspection readiness is continuous, not periodic.
Every Workflow Your Biopharma Lab Runs
Bioanalytical Studies
Manage the complete bioanalytical study lifecycle — from protocol design through sample analysis to regulatory submission. LIMSera tracks PK/PD studies, bioequivalence trials, method validation runs, and stability-indicating assays within a structured study framework. Each study carries its own protocol, acceptance criteria, calibration curve requirements, and QC sample rules. Incurred sample reanalysis (ISR) and cross-validation workflows are built in. The system enforces GLP compliance at every step — from sample chain-of-custody through electronic signatures on the final study report.
The Biopharma Study Lifecycle, End To End
Study Protocol & Design
Define the study with protocol parameters, acceptance criteria, sample size, analytical runs, and QC sample rules. Protocol versions are controlled with electronic approval. Regulatory templates for FDA, EMA, and PMDA submissions are pre-configured.
Sample Accessioning & Chain-of-Custody
Samples are received with barcode scanning, condition verification, and storage assignment. The chain-of-custody record begins at receipt and tracks every transfer, aliquoting event, and freeze-thaw cycle through to final disposition.
Instrument-Integrated Analysis
Analytical runs execute per the validated method. HPLC, LC-MS/MS, and other instrument data flows directly into LIMSera. Calibration curves, QC samples, and system suitability checks are evaluated automatically against pre-defined acceptance criteria.
Data Review & Integrity Check
Results undergo automated data integrity verification — ALCOA+ compliance, audit trail review, and electronic signature validation. AI flags anomalous chromatographic patterns, unexpected peak shapes, and results inconsistent with the study's historical data.
QA Review & Approval
Quality Assurance reviews the complete study package — raw data, calculations, deviations, audit trails, and investigator conclusions. Each approval tier carries electronic signature with meaning declaration. Rejected items return to the analyst with documented rationale.
Study Report & Submission
The final study report is assembled automatically from approved data, validated methods, deviation summaries, and QA attestations. Regulatory submission packages are formatted per FDA, EMA, or PMDA requirements and delivered in eCTD-ready structure.
Everything Your Biopharma Lab Needs
Study & Protocol Management
Define studies with protocols, acceptance criteria, sample schedules, and analytical runs. Every study maintains its own controlled document set, audit trail, and regulatory submission package.
Electronic Lab Notebook
Structured experiment capture with versioned entries, electronic signatures, and full-text search. Observations, calculations, and conclusions linked to raw data and instrument output.
Method Validation Suite
Pre-configured validation protocols for specificity, linearity, accuracy, precision, LOD/LOQ, robustness, and stability indication per ICH Q2(R2) and FDA/EMA bioanalytical guidelines.
Stability Chamber Integration
Direct monitoring of temperature, humidity, and light exposure in stability chambers. Automatic pull schedule generation, excursion alerts, and shelf-life prediction modelling.
21 CFR Part 11 Compliance
Electronic records with audit trails, electronic signatures with meaning declarations, system access controls, and data integrity safeguards meeting FDA 21 CFR Part 11 and EU Annex 11.
Equipment Qualification (IQ/OQ/PQ)
Structured qualification protocols for installation, operational, and performance qualification of instruments. Qualification status linked to analytical data validity.
AI-Powered OOS Investigation
When out-of-specification results occur, AI guides the Phase I/Phase II investigation. Root cause probability scoring, assignable cause analysis, and decision tree documentation.
ALCOA+ Audit Trail
Every data point is Attributable, Legible, Contemporaneous, Original, and Accurate. The audit trail captures who, what, when, and why for every action in the system.
Instrument Integration
Direct data acquisition from HPLC, GC, LC-MS/MS, dissolution apparatus, Karl Fischer, and spectrophotometers. Chromatographic data systems interfaced for peak integration and reporting.
Multi-Site Harmonisation
Standardise methods, specifications, and workflows across multiple laboratories and CRO partners. Cross-site data comparison and method transfer tracking from a single deployment.
From Protocol To Regulatory Submission. Every Data Point Defended.
Bioanalytical studies demand absolute data integrity — every calibration curve, every QC sample, every incurred sample reanalysis must be documented, reviewed, and defensible under regulatory scrutiny. LIMSera structures the entire study lifecycle: protocol creation with version control, sample accessioning with unbroken chain-of-custody, analytical run management with automated acceptance criteria evaluation, and multi-tier review with electronic signatures.
The system doesn't just store data — it enforces the rules. If a calibration curve doesn't meet acceptance criteria, the affected samples are automatically flagged for reanalysis. If QC samples fail, the run is rejected with documented rationale. ISR triggers are evaluated automatically based on the protocol's defined rules. The result is a study package that arrives at regulatory review already defended.
Data Integrity Built Into Every Workflow. Not Checked After The Fact.
Data integrity failures are the single largest cause of FDA warning letters in pharmaceutical laboratories. LIMSera eliminates the conditions that produce them. Every data entry is timestamped and attributed. Every modification is captured with a reason code. Every electronic signature carries a meaning declaration. The audit trail is immutable — not even system administrators can alter historical records.
When results fall outside specification, LIMSera's AI doesn't just flag the failure — it guides the investigation. Phase I root cause analysis evaluates laboratory error probability based on instrument performance history, analyst proficiency data, and method validation parameters. If Phase I finds no assignable cause, Phase II investigation workflows extend to process and manufacturing review. Every investigation step is documented, every decision traceable.
Regulatory Packages That Assemble Themselves.
Regulatory submissions require data from across the laboratory — method validation reports, stability data summaries, batch analysis certificates, OOS investigation closures, and equipment qualification records. In most labs, assembling this package is a weeks-long manual exercise of pulling data from multiple systems, reformatting tables, and cross-referencing document numbers.
LIMSera generates submission-ready packages automatically. Method validation summaries compile from the validation study data. Stability reports aggregate across time points and conditions. Batch release certificates pull from approved QC results. OOS investigation closures include the complete decision tree and CAPA documentation. Every element is formatted per the target regulatory authority — FDA, EMA, or PMDA — and structured for eCTD compatibility.
Regulatory Compliance Built Into Every Workflow.
ALCOA+ Audit Trail
Every data action is Attributable, Legible, Contemporaneous, Original, and Accurate. Complete audit trails with reason codes for every modification.
Equipment Qualification
Structured IQ/OQ/PQ protocols with documented acceptance criteria. Qualification status linked to analytical data validity and instrument usage permissions.
Deviation & OOS Management
Phase I/Phase II OOS investigation workflows with AI-guided root cause analysis. Deviation classification, impact assessment, and CAPA linkage.
Electronic Signatures
21 CFR Part 11 compliant electronic signatures with meaning declarations (authored, reviewed, approved). Biometric or password-based authentication.
Designed For Every Role In Your Biopharma Organisation
End-to-end study visibility, protocol management, milestone tracking, and regulatory submission package oversight
Guided analytical run execution, instrument data integration, automated QC evaluation, and electronic notebook for observations
Specification-based disposition, stability programme oversight, OOS investigation management, and batch release dashboards
ALCOA+ audit trail review, deviation tracking, CAPA oversight, electronic signature administration, and inspection readiness
Submission-ready data packages, method validation summaries, stability data compilation, and regulatory correspondence tracking
Real-time study progress visibility, milestone notifications, report access, and data transfer through secure sponsor portal
Frequently Asked Questions
Ready To Modernise Your Biopharma Laboratory?
See LIMSera configured for your study types, your regulatory requirements, and your data integrity needs.
A live walkthrough configured for your laboratory. No generic demos.